According to the Israel Export Institute, technology services exports rose by 11% in 2020 to $37 billion, double the figure for 2014.
Tel Aviv University virus expert Prof. Jonathan Gershoni tells you everything you wanted to know about the new mutations but were afraid to ask.
With automated loan finder Fuse, VC and former entrepreneur Elie Wurtman hopes to repeat his success with Vroom, but to keep it made in Israel.
Several faces in the new administration are familiar from the Obama era, but Donald Trump has left the Middle East a very different place.
Israel's former Health Ministry head of public health services cautions against thinking the vaccine will vanquish the virus.
Building a network is not optional; establishing relationships with the local startup ecosystem is key.
Assuming President Biden demonstrates the fortitude to hold off the extremists in his party, he is not a bad prospect, for the US, for the world, and for Israel.
Israel's leading private equity firm has been very active in the healthcare sector lately, but not just there.
The Supreme Court has upheld the Israel Tax Authority's narrow approach to exemptions for New Israeli Residents.
Data from Yad2's real estate site shows that interest in moving away from city centers has surged during the Covid-19 pandemic.
Announcing foreign currency purchases in advance has worked wonders but the forces strengthening the shekel remain the same.
CFO Ronen Faier explains the strategy and culture that led SolarEdge to becoming the most valuable Israeli company on Wall Street.
The neighborhoods ranked as top quality by Israel's Central Bureau of Statistics have surprisingly reasonable prices.
Experts are alarmed about possible breaches of confidentiality and the lack of transparency in Israel's vaccine deal with Pfizer.
ExoProTher Medical is using the body's own anti-cancer agent to treat brain cancer.